Capital One Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,027
Closed -$356K 152
2021
Q4
$356K Buy
6,027
+224
+4% +$11.1K 0.04% 143
2021
Q3
$250K Buy
5,803
+127
+2% +$5.63K 0.03% 165
2021
Q2
$222K Buy
+5,676
New +$221K 0.03% 180
2021
Q1
Sell
-5,430
Closed -$200K 198
2020
Q4
$200K Sell
5,430
-2,124
-28% -$77.9K 0.03% 190
2020
Q3
$263K Sell
7,554
-1,998
-21% -$70K 0.03% 224
2020
Q2
$296K Sell
9,552
-2,046
-18% -$69.5K 0.04% 241
2020
Q1
$359K Buy
+11,598
New +$395K 0.06% 218

Other funds holding PFE

Capital One Financial's PFE Position: Q1 2022 in Review

Capital One Financial sold out of Pfizer (PFE) in Q1 2022, closing a stake of 6,027 shares — an estimated $356K sold.

Capital One Financial first reported a position in PFE in Q1 2020 and held it in 7 quarters. The position peaked at $359K in Q1 2020. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Capital One Financial reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Capital One Financial sold 6,027 Pfizer shares in Q1 2022, an estimated $356K.
  • Capital One Financial first reported a position in Pfizer in Q1 2020 and held it in 7 quarters.
  • Capital One Financial's Pfizer position peaked at $359K in Q1 2020.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Capital One Financial's 13F filing for Q1 2022, filed 13 Apr 2022.